Published February 13, 2026 | Version v1
Publication Open

Discovery of BDT272, an orally available FLT3 negative allosteric modulator for the treatment of peripheral neuropathic pain

  • 1. Laboratoire d'innovation thérapeutique, UMR7200 CNRS-Université de Strasbourg

Description

Supplementary information

Files

ADME-Tox.pdf

Files (15.5 MB)

Name Size Download all
md5:a42895c6d7a4ddb36168a56e201744d5
341.5 kB Preview Download
md5:c2c576de8887efcadd7e1927dea74cf1
3.6 MB Preview Download
md5:5abc04b8fd9d70ba1fdab8215fe2ebd6
196.0 kB Preview Download
md5:016b4594ea69fdb520278ae351c150df
633.0 kB Preview Download
md5:420ddcf19d2e14956bfbb592d0265f23
3.7 MB Preview Download
md5:26fda52c634296643e4b85d6bddfa016
888.0 kB Preview Download
md5:ee0c37d22e157511075a750931aabe73
621.7 kB Preview Download
md5:51421924f169939624c1fdb346926afb
2.2 MB Preview Download
md5:ea229c723383604aac331a23e81d80fa
925.4 kB Preview Download
md5:543cb129f92c7fc785207122f02738f7
2.4 MB Preview Download